BioSpace News Archive

TELA Bio, Inc. announced that additional data from its BRAVO study were presented virtually as posters at the Americas Hernia Society Annual Meeting.

CB2 Insights Inc. (“ CB2 ” or the “ Company ”) (CSE: CBII; OTCQB: CBIIF), one of the largest integrative healthcare systems in the United States, is pleased to announce that it has upsized and closed its previously announced non-brokered private placement financing (the “Placement”) of units of the Company (the “Units”) led by Merida Capital Partners. The Company issued 34,253,641 Units at an issue price of C$0.15 per Unit (the “Issue Price”) for

Freeline Therapeutics Holdings plc announced that Theresa Heggie, Chief Executive Officer, will present at the Chardan Virtual 4th Annual Global Healthcare Conference on October 6 at 4:45pm EDT.

Endo International plc announced that its subsidiary, Par Sterile Products, LLC has entered into a non-exclusive agreement with Novavax, Inc. to provide fill-finish manufacturing services at its plant in Rochester, Michigan for NVX-CoV2373, Novavax’ COVID-19 vaccine candidate.

AVROBIO, Inc . (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced that members of its senior management team are scheduled to participate in two upcoming virtual investor conferences. Jefferies Virtual Gene Therapy/Editing Summit Date: Thursday, Oct. 1, 2020 Time: 12:30 p.m. ET Chardan Virtual 4 th Annual Gen

Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, today announced that Steven Nichtberger, M.D., President and Chief Executive Officer, will present at the following three upcoming investor conferences in Octobe

Otorhinolaryngology is a surgical specialty in medicine, which overlooks the management of conditions affecting the head and neck. It includes both medical and surgical management of various conditions of ear, nose, and throat.

Causes of respiratory tract infection vary significantly across each indication, and include factors such as environment, occupation, genetic predisposition, and aging

From 2020 to 2030, the global seasonal affective disorder is set to witness new profitable avenues.

Dr. Reddy’s Laboratories Ltd. announced the launch of Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, a therapeutic equivalent generic version of Precedex® in 0.9% Sodium Chloride Injection, approved by the U.S. Food and Drug Administration.